{
    "2019-11-23": [
        [
            {
                "time": "2018-11-01",
                "original_text": "UPDATE 1-Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 bln- WSJ",
                "features": {
                    "keywords": [
                        "Novartis",
                        "deal",
                        "buy",
                        "U.S.",
                        "biotech",
                        "Medicines Co",
                        "$7 bln"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ",
                "features": {
                    "keywords": [
                        "Novartis",
                        "deal",
                        "buy",
                        "U.S.",
                        "biotech",
                        "Medicines Co",
                        "$7 billion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-01",
                "original_text": "Novartis nears $9bn deal to buy cholesterol drugmaker",
                "features": {
                    "keywords": [
                        "Novartis",
                        "deal",
                        "buy",
                        "cholesterol",
                        "drugmaker",
                        "$9bn"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}